
Promise and Pitfalls in Taking Psychedelic Medicine Mainstream
Cato Podcast
00:00
Psychedelics
Many drugs that could be useful clinically aren't owned. Big pharma look for something they can derive exclusive revenues from over time. Psychadelic companies have tried to patent various a crystalline latices of silasivon. These are ploys that have been a done by big farma for many years. And an attempt to patent, if they will, essentially unpatentable items.
Transcript
Play full episode